This article provides a state-of-the-art review on landiolol, a medication that was recently
submitted for 7 approvals. Focusing on its pharmacology, pharmacokinetics, and …

Landiolol is an ultra-short-acting, selective β1-adrenergic receptor blocker that was
originally approved in Japan for the treatment of intraoperative tachyarrhythmias. It has …

Background: The highly β1-selective beta-blocker Landiolol is known to facilitate efficient
and safe rate control in non-compensatory tachycardia or dysrhythmia when administered …

Purpose Postoperative atrial fibrillation (POAF) is a common complication following cardiac
surgery. Although the evidence suggests that beta blockers prevent POAF, they often cause …

Послеоперационная фибрилляция предсердий (ПОФП)-одно из наиболее
распространенных ослож нений после кардиохирургических вмешательств, которое …

Early postoperative left ventricular dysfunction due to myocardial stunning can negatively
affect outcomes in patients with mitral regurgitation undergoing mitral valve surgery. The aim …

Landiolol is an ultra-short-acting, selective ß1-adrenergic receptor blocker that was
originally approved by Japan for the treatment of intraoperative tachyarrhythmias. It has …

Vorhofflimmern (VHF) ist i. Allg. und auch perioperativ die häufigste Herzrhythmusstörung
bei Erwachsenen und mit einer substanziellen Morbidität und Letalität assoziiert. Ein …

Background: Landiolol is a new ultra-short-acting beta-1-selective beta-blocker which was
introduced and approved in the European Union (EU) in recent years. As other beta …